RGS22 Antikörper (AA 201-504)
-
- Target Alle RGS22 Antikörper anzeigen
- RGS22 (Regulator of G-Protein Signaling 22 (RGS22))
-
Bindungsspezifität
- AA 201-504
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RGS22 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Regulator of G-protein signaling 22 protein (201-504AA)
- Isotyp
- IgG
- Top Product
- Discover our top product RGS22 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- RGS22 (Regulator of G-Protein Signaling 22 (RGS22))
- Andere Bezeichnung
- RGS22 (RGS22 Produkte)
- Synonyme
- PRTD-NY2 antikoerper, RGD1565493 antikoerper, regulator of G protein signaling 22 antikoerper, regulator of G-protein signaling 22 antikoerper, regulator of G-protein signalling 22 antikoerper, RGS22 antikoerper, Rgs22 antikoerper
- Hintergrund
-
Background: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form.
Aliases: FLJ40080 antibody, FLJ75004 antibody, MGC102908 antibody, PRTD-NY2 antibody, Regulator of G-protein signaling 22 antibody, RGS22 antibody, RGS22_HUMAN antibody
- UniProt
- Q8NE09
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
-